Form 4: Prestige Consumer Healthcare CFO Equity Transaction

Sentiment:

Statement of Changes in Beneficial Ownership


CFO and COO Christine Sacco acquired 18,984 shares of Prestige Consumer Healthcare Inc. through PSU settlement and restricted stock grants.

Summary

  • CFO and COO Christine Sacco acquired 7,008 shares of common stock via the settlement of performance stock units (PSUs) granted in 2023.
  • The reporting person disposed of 3,434 shares to satisfy tax withholding obligations at a price of $55.31 per share.
  • An additional grant of 11,976 restricted stock units was awarded, vesting in three equal annual installments starting May 4, 2027.
  • Following these transactions, the reporting person's total beneficial ownership increased to 73,894 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure of executive compensation and equity ownership changes, carrying no significant market-moving sentiment.

Positives

  • The acquisition of shares through PSU settlement indicates the achievement of performance goals related to per-share growth.
  • The receipt of restricted stock units aligns the executive's long-term interests with those of shareholders.

Negatives

  • The transaction involved a tax-related disposition of 3,434 shares, which is a standard administrative action but reduces the net share increase.

Risks

  • Future vesting of restricted stock is subject to continued employment and potential performance conditions.

Future Outlook

The reporting person holds 11,976 restricted shares that will vest in equal installments on May 4, 2027, 2028, and 2029, contingent on continued service.

Industry Context

StockSavvy.ai notes that executive equity transactions of this nature are standard practice in the consumer healthcare sector to ensure management retention and alignment with long-term shareholder value creation.

Comparison to Industry Standards

  • The use of performance-based equity and time-vested restricted stock is consistent with compensation structures at peer companies like Church & Dwight and Perrigo.

Stakeholder Impact

  • Positive alignment of executive interests with shareholders through long-term equity incentives.

Next Steps

  • Vesting of restricted stock installments on May 4, 2027, May 4, 2028, and May 4, 2029.

Key Dates

DateDescription
05/04/2026Date of earliest transaction involving PSU settlement and restricted stock grant.
05/06/2026Date of filing.
05/04/2027First vesting date for the new restricted stock grant.

Keywords

Prestige Consumer Healthcare, PBH, Insider Trading, Form 4, Executive Compensation, CFO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.